Evaluation of the Cost-Effectiveness of Evidence-Based Interventions to Increase Female Breast and Cervical Cancer Screens: A Systematic Review
Open Access
Abstract
Purpose: To systematically review published cost-effectiveness analyses of Evidence-Based Interventions (EBIs) recommended by the United States Community Preventive Services Task Force (CPSTF) to increase breast and cervical cancer screening. Methods: We searched PubMed and Embase for prospective cost-effectiveness evaluations of EBIs for breast and cervical cancer screening since 1999. We reviewed studies according to the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) and compared the incremental cost-effectiveness ratio (ICERs), defined as cost per additional woman screened, adjusted to 2021 USD, within and across EBIs by cancer type. Results: We identified eleven studies meeting our review criteria: nine were breast cancer-focused, one breast and cervical cancer combined, and one cervical only, which together reported twenty-four cost-effectiveness assessments of outreach programs spanning eight EBIs. One-on-one education programs were the most common EBI evaluated. The average ICER across breast cancer studies was USD 545 (standard deviation [SD] = USD 729.3), while that for cervical cancer studies was USD 197 (SD = 186.6. Provider reminder/recall systems for women already linked to formal care were the most cost-effective, with an average ICERs of USD 41.3 and USD 10.6 for breast and cervical cancer, respectively. Conclusions: Variability in ICERs across and within EBIs reflect the population studied, the specific EBI, and study settings, and was relatively high. ICER estimate uncertainty and the potential for program replicability in other settings and with other populations were not addressed. Given these limitations, using existing cost-effectiveness estimates to inform program funding allocations is not warranted at this time. Additional research is needed on outreach programs for cervical cancer and those which serve minority populations for either of the female cancer screens.Keywords
Funding Information
- Centers for Disease Control and Prevention (CDC) (SIP 19-006)
This publication has 34 references indexed in Scilit:
- Technology-Delivered Intervention Strategies to Bolster HIV TestingCurrent HIV/AIDS Reports, 2021
- Interventions to increase breast and cervical cancer screening uptake among rural women: a scoping reviewCancer Causes & Control, 2020
- Economics of public health programs for underserved populations: a review of economic analysis of the National Breast and Cervical Cancer Early Detection ProgramCancer Causes & Control, 2019
- Economics of Multicomponent Interventions to Increase Breast, Cervical, and Colorectal Cancer Screening: A Community Guide Systematic ReviewAmerican Journal of Preventive Medicine, 2019
- Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection ProgramCancer Causes & Control, 2019
- Results of a randomized controlled trial to increase cervical cancer screening among rural LatinasCancer, 2016
- Breast Cancer Screening for Women at Average RiskJAMA, 2015
- Breast cancer screening of underserved women in the USA: results from the National Breast and Cervical Cancer Early Detection Program, 1998–2012Cancer Causes & Control, 2015
- Costs and Cost-effectiveness of a Clinical Intervention to Increase Mammography Utilization in an Inner City Public Health HospitalPreventive Medicine, 2002
- Cost–Effectiveness Comparison of Five Interventions to Increase Mammography ScreeningPreventive Medicine, 1999